Director of ILD @KeckMedUSC. @imperialNHLI Honorary Prof of Interstitial Lung Disease and #IPF doctor. Working to #cureIPF
Joined March 2012
- Tweets 724
- Following 503
- Followers 3,279
- Likes 610
32 Photos and videos
Toby Maher retweeted
May 31
The first snRNASeq & spatial transcriptomic analysis of bronchoscopic cryobiopsies from patients with Early IPF & preserved pulmonary functions is out on @biorxivpreprint and message is Early IPF is IPF‼️
biorxiv.org/content/10.64898…
3
24
69
9,899
Toby Maher retweeted
7 Nov 2025
Feat: @TobyMMaher, Justin Oldham MD, and Marlies Wijsenbeek MD
Moderaters: @CarlaRCopeland and Ayodeji Adegunsoye MD
@ATS_Assemblies
1
3
304
Shoutout to @drcastelino, @tobymmaher, and Dr. Flaherty for leading an amazing discussion at #CHEST2025! Real-world takeaways for real-world care.
📺 Replay available here: bit.ly/FibrosingILDT
Thanks to @Boehringer for their educational grant support #CME #MedEd
4
9
348
Watch Toby Maher, MD, MSc, PhD (@TobyMMaher), Flavia Castelino, MD (@drcastelino), and Kevin R. Flaherty, MD, MS discuss clearing the air on fibrosing ILDs at #CHEST2025 – to participate, visit: bit.ly/FibrosingILDT x.com/i/broadcasts/1mrGmBbkW…
4
10
302
Join Toby Maher, MD, MSc, PhD (@tobymmaher), Flavia Castelino, MD (@drcastelino), and Kevin R. Flaherty, MD, MS, on 10/21 at 6:00 AM CDT during #CHEST2025 for a #fibrosingILD #MedEd event.
🔗 bit.ly/FibrosingILDT
#pulmonology
3
9
345
Toby Maher retweeted
8 Oct 2025
Yesterday, the U.S. FDA approved Jascayd (nerandomilast) to treat IPF. This is the first IPF new therapy approved in more than a decade.
Congratulations to all our patients & yes, even better drugs are on the way!!
Great day for #CureIPF
#ScienceMatters
fda.gov/drugs/news-events-hu…
4
10
34
2,297
Toby Maher retweeted
8 Oct 2025
⚡ Up your #fibrosingILD game! Join @PeerView the experts Drs. Toby Maher (@tobymmaher) & Castelino (@drcastelino) at #CHEST2025 (Oct 21 | 6 AM CDT) for a rapid-fire TownHall on antifibrotics, immunomodulators & emerging therapies. 🫁
👉 bit.ly/FibrosingILDT #MedEd
3
7
333
Toby Maher retweeted
29 Sep 2025
🚨 Stay ahead in #fibrosingILD care! Join @PeerView with Drs. Maher (@tobymmaher) & Castelino (@drcastelino) at #CHEST2025 on 10/21 at 6 AM CDT for a TownHall on diagnosis, management & emerging therapies. Register: bit.ly/FibrosingILDT #MedEd #pulmonology #ILD
5
6
357
"#FibrosingILD: Conversations on Timely Diagnosis and Antifibrotic Therapy” with Drs. Maher (@tobymmaher) & Castelino (@drcastelino). 10/21 at 6:00 AM CDT. bit.ly/FibrosingILDT #CHEST2025 #pulmonology
3
7
401
Toby Maher retweeted
29 Aug 2025
What do most clinicians miss about idiopathic pulmonary fibrosis?
Find out in the latest episode, where @doctor_saranya speaks with @TobyMMaher about what defines Interstitial Lung Disease, how idiopathic pulmonary fibrosis fits into the picture and more: hubs.la/Q03G8R-W0
4
8
475
Toby Maher retweeted
2 Jun 2025
Fantastic news for all our patients with IPF who suffer with cough! An overall 43% reduction in cough counts, similar improvement in patient reported cough and benefits seen in 2 weeks. We look forward to the phase 3 study!
2 Jun 2025
We are pleased to share the positive topline results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough.
Join our conference call today, June 2nd, at 8:30 a.m. ET.
Read the press release: ow.ly/MCzh50W2spG
$TRVI
12
45
2,233
Toby Maher retweeted
19 May 2025
When it rains it pours!! What an amazing #ATS2025 for #CurePF4ALL! Nerandomilast -> ⬇️FVC decline compared to placebo in Progressive Pulmonary Fibrosis patients on antifibrotics or untreated. 👏🏼 Drs Maher, Martinez & #FibroneerILD team!!
nejm.org/doi/full/10.1056/NE…
1
19
78
6,773
Toby Maher retweeted
19 May 2025
Wow! What a day for #CureIPF & #ATS2025! First positive drug trial in 10 years in IPF!! Treatment with Nerandomilast -> ⬇️FVC decline compared to placebo in patients on antifibrotics or untreated. Kudos Drs Richeldi and Wijsenbeek and #FibroneerIPF team nejm.org/doi/full/10.1056/NE…
2
33
107
9,169
18 May 2025
Great to see publication of the first positive phase 3 trial in patients with IPF. This represents an important step forward in the treatment of this terrible disease. #cureipf
Presented at #ATS2025:
In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: nej.md/4mgWcIU
@atscommunity
ALT A bar chart showing the change from baseline in forced vital capacity at week 52 in the overall trial population
2
14
47
2,787
Toby Maher retweeted
14 May 2025
A reminder to tune in to our session at #ATS2025 on cough in pulmonary fibrosis. Join @TobyMMaher to discuss how new technologies and patient-reported outcomes can address this gap in IPF research.
Add to your calendar and join us! calendarlink.com/event/8aCAe
#IPF #digitalhealth
1
3
279
Toby Maher retweeted
14 May 2025
#ArtificialIntelligence and the Diagnosis of #InterstitialLungDisease: Are We Ready for ChatMDT?!
onlinelibrary.wiley.com/doi/…
an Editorial by @TobyMMaher on recent research:
onlinelibrary.wiley.com/doi/…
Follow us on Bluesky: @respirology.bsky.social
1
6
11
866
Toby Maher retweeted
1 May 2025
Join Strados Labs and @TobyMMaher at #ATS2025 for an engaging session on the often-overlooked symptom of cough in pulmonary fibrosis and ways we can address the gap.
May 19, 11:55 AM PST | Exhibitor Hall Innovation Hub #7
We look forward to seeing you there! #IPF
2
3
294
Toby Maher retweeted
14 Apr 2025
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non-Responders in IPF?
onlinelibrary.wiley.com/doi/…
and Editorial by Toby Maher @tobymmaher on recent research:
onlinelibrary.wiley.com/doi/…
Follow us on Bluesky: @respirology.bsky.social
1
3
432
Toby Maher retweeted
20 Mar 2025
Fibrosis: cross-organ biology and pathways to development of innovative drugs nature.com/articles/s41573-0…
This new Review highlights core pathways active in fibrotic conditions across organs, and proposes strategies to improve the translation of potential antifibrotic drugs
56
196
15,466
Toby Maher retweeted
12 Feb 2025
Join us for the next episode in the specialty series on Tuesday 18 February at 6.30pm!
Our panel @R_tattersall, @Sarah_L_Mackie and @TobyMMaher will discuss key updates in rheumatology.
Followed by a question and answer session.
Book your place now: ow.ly/cLri50UXRCi
1
2
6
1,099